Marex Group’s Bioventus BVS Stock Holding History

Marex Group’s Portfolio BVS Stock Details BVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-23,313	Closed	-$156K	–	1000
2025 Q3	$156K	Buy	+23,313	New	+$162K	﹤0.01%	746

Other funds holding BVS

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

JIC

Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Marex Group's BVS Position: Q4 2025 in Review

Marex Group sold out of Bioventus (BVS) in Q4 2025, closing a stake of 23,313 shares — an estimated $156K sold.

Marex Group first reported a position in BVS in Q3 2025 and held it in 1 quarter. The position peaked at $156K in Q3 2025. 148 funds tracked by Wall St. Rank hold BVS as of Q4 2025.

Marex Group reported no remaining Bioventus position as of Q4 2025 after selling out during the quarter.
Marex Group sold 23,313 Bioventus shares in Q4 2025, an estimated $156K.
Marex Group first reported a position in Bioventus in Q3 2025 and held it in 1 quarter.
Marex Group's Bioventus position peaked at $156K in Q3 2025.
148 funds tracked by Wall St. Rank held Bioventus as of Q4 2025.

Based on Marex Group's 13F filing for Q4 2025, filed 12 Feb 2026.